US Patent 11008337 Chiral diaryl macrocycles as modulators of protein kinases
Patent 11008337 was granted and assigned to Turning Point Therapeutics on May, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11008337 Chiral diaryl macrocycles as modulators of protein kinases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
